Skip to content

The stress-axis in multiple sclerosis: Clinical, cellular and molecular aspects

Unknown authors
View source

Similar papers

Review Aug 2026

Cortisol Dysregulation as a Major Factor in the Development of Neurodegenerative Diseases, Drug Targets and Therapeutic Prospects: A Comprehensive Review.

Cortisol, regulated by the hypothalamic-pituitary-adrenal (HPA) axis, is critical for stress response, metabolism, and immune function. Its dysregulation is increasingly implicated in neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic latera...

Reza Hooshyari Ardakani, Mohadeseh Dashtaki, Seyed-Mahdi Mohamadi-Zarch et al. · 0 citations
Review Open access Aug 2026

Mechanisms and Clinical Assessment of Fear of Disease Progression in Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive, life-limiting neurodegenerative disease characterized primarily by motor dysfunction, although cognitive and behavioral impairment occurs in a substantial subset of patients. Progressive functional decline and prognostic uncertainty may contribute to pronounced fear...

Ting Wang, Tao Jin, Zhuo-Yi Cai et al. · 0 citations
Review Open access Sep 2026

ERBB4 and Neurodegeneration: Association Between Hypothalamic–Pituitary–Adrenal (HPA) Axis: Associated Neurodegenerative Pathogenesis

The hypothalamic–pituitary–adrenal (HPA) axis is the central neuroendocrine system that controls physiological stress responses and maintains homeostasis through the coordinated interactions among the hypothalamus, pituitary gland, and adrenal cortex. Dysregulation of the HPA axis is associated with stress-related psyc...

Eva Bagyinszky, Seong Soo A. An · 0 citations
Review Open access Aug 2026

Research Progress on the Gut–Brain Axis in the Pathogenesis and Progression of Alzheimer’s Disease

Memory impairment and broader cognitive decline emerge gradually in Alzheimer’s disease (AD), although amyloid-β deposition, tau abnormalities, and neuroinflammatory changes often develop well before the clinical picture is fully established. Drug therapy can lessen selected symptoms, but it does not prevent continuing...

Yu-Jie Gao · 0 citations
Review Open access Sep 2026

Immunometabolic Dysregulation and Cognitive Dysfunction in Major Depressive Disorder: The Role of Chronic Low-Grade Inflammation

Major depressive disorder is a heterogeneous psychiatric condition frequently accompanied by persistent cognitive dysfunction involving executive function, attention, memory, processing speed, and motivational processes. Increasing evidence suggests that chronic low-grade inflammation and immunometabolic dysregulation...

Juan José Parra Serpa, Catalina Antonia de Jesús, Anabel Stephanny Ortiz Dávila et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.